FAQ
Log In
Friday 2nd December 2016
News
 › 
 › 

New prostate cancer test

22nd November 2006

A new probe to diagnose prostate cancer has been unveiled by experts.

Prostate cancer is the most common form of cancer among men and is usually found in the over 50s.

Now a simple urine test could help to more accurately diagnose sufferers and improve treatment.

The new device has been launched by Gen-Probe which will detect the cancer by measuring the gene PCA3 mRNA in urine, which evidence shows is 60 to 100 times over-expressed in more than 95 per cent of prostate cancer cases.

If successfully introduced, it could help to reduce the number of unnecessary biopsies carried out on patients as part of their diagnosis.

The device was launched by at the annual meeting of the British Association of Urological Surgeons Section of Oncology (BAUS).

The test has been CE marked which allows it to be marketed in the European Union.


Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016